TOKYO (Reuters) – On Monday Sony tops the list of groups approached to forge a partnership with Olympus, the financial weekly reported on its website, while the specialist has all the optical difficulty in get out of an accounting fraud scandal that has weakened its finances.
Olympus could organize a press conference this week to announce the formation of a partnership with Sony that would increase its stake in the manufacturer of endoscopes and cameras, currently at 0.03%, writes Diamond.
The publication quoted an official from Sony, it did not identify, said Howard Stringer, the CEO of Sony, gave the green light for the operation.
By increasing its stake in Olympus, Sony medical equipment would add to its portfolio, a profitable business that the group had so far kept away.
A Sony spokesman declined to comment on information, while a spokesman for Olympus said that no press conference had been scheduled and no decision was for the time taken in this matter.